{"id":131446,"date":"2026-06-26T10:25:55","date_gmt":"2026-06-26T04:55:55","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=131446"},"modified":"2026-06-26T10:25:56","modified_gmt":"2026-06-26T04:55:56","slug":"vineet-laboratories-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/","title":{"rendered":"Vineet Laboratories Share Price Target 2026 Analyst Forecast Bull and Bear Case"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>The Vineet Laboratories share price target 2026 is Rs 41.1, implying approximately 20 percent upside from the current market price of Rs 34.25 (NSE: VINEETLAB). With Q4 FY26 results released in 2026 and Pharmaceutical Formulations tailwinds in focus, the Rs 41.1 price objective is supported by the FY27 earnings recovery thesis.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/stocks\/vineetlab\/vineet-laboratories-ltd-share-price-today\">Vineet Laboratories<\/a> (NSE: VINEETLAB) is a Pharmaceutical Formulations company trading at Rs 34.25 with a market capitalisation of Rs 120 crore. Analysts have set the <strong>Vineet Laboratories share price target<\/strong> at Rs 41.1 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast including sector tailwinds, key risks, and bull and bear scenarios.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Vineet_Laboratories_Share_Price_Target_2026_Key_Takeaways\" title=\"Vineet Laboratories Share Price Target 2026: Key Takeaways\">Vineet Laboratories Share Price Target 2026: Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Vineet_Laboratories_Company_Overview\" title=\"Vineet Laboratories Company Overview\">Vineet Laboratories Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Why_Is_the_Vineet_Laboratories_Share_Price_Target_Set_at_Rs_411_for_2026\" title=\"Why Is the Vineet Laboratories Share Price Target Set at Rs 41.1 for 2026\">Why Is the Vineet Laboratories Share Price Target Set at Rs 41.1 for 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#FY27_Earnings_Recovery_and_Revenue_Acceleration\" title=\"FY27 Earnings Recovery and Revenue Acceleration\">FY27 Earnings Recovery and Revenue Acceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Structural_Sector_Tailwinds_in_Pharmaceutical_Formulations\" title=\"Structural Sector Tailwinds in Pharmaceutical Formulations\">Structural Sector Tailwinds in Pharmaceutical Formulations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\" title=\"RBI Rate Cut Cycle and Lower Cost of Capital\">RBI Rate Cut Cycle and Lower Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Union_Budget_2026-27_Capex_Push_and_Policy_Support\" title=\"Union Budget 2026-27 Capex Push and Policy Support\">Union Budget 2026-27 Capex Push and Policy Support<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#FII_Flow_Normalisation_After_the_2026_Tariff_Shock\" title=\"FII Flow Normalisation After the 2026 Tariff Shock\">FII Flow Normalisation After the 2026 Tariff Shock<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Vineet_Laboratories_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\" title=\"Vineet Laboratories Share Price Targets: Short Term, 12 Month, and Long Term\">Vineet Laboratories Share Price Targets: Short Term, 12 Month, and Long Term<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Short_Term_Vineet_Laboratories_Share_Price_Target\" title=\"Short Term Vineet Laboratories Share Price Target\">Short Term Vineet Laboratories Share Price Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#12-Month_Vineet_Laboratories_Share_Price_Target_2026\" title=\"12-Month Vineet Laboratories Share Price Target 2026\">12-Month Vineet Laboratories Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Long_Term_Vineet_Laboratories_Share_Price_Target_FY27_to_FY28\" title=\"Long Term Vineet Laboratories Share Price Target: FY27 to FY28\">Long Term Vineet Laboratories Share Price Target: FY27 to FY28<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Bull_Case_and_Bear_Case_Scenarios_for_Vineet_Laboratories_in_2026\" title=\"Bull Case and Bear Case Scenarios for Vineet Laboratories in 2026\">Bull Case and Bear Case Scenarios for Vineet Laboratories in 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Bull_Case_Vineet_Laboratories_Share_Price_Target_Rs_497\" title=\"Bull Case Vineet Laboratories Share Price Target: Rs 49.7\">Bull Case Vineet Laboratories Share Price Target: Rs 49.7<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Bear_Case_Vineet_Laboratories_Share_Price_Target_Rs_274\" title=\"Bear Case Vineet Laboratories Share Price Target: Rs 27.4\">Bear Case Vineet Laboratories Share Price Target: Rs 27.4<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Key_Risks_That_Could_Derail_the_Vineet_Laboratories_2026_Price_Objective\" title=\"Key Risks That Could Derail the Vineet Laboratories 2026 Price Objective\">Key Risks That Could Derail the Vineet Laboratories 2026 Price Objective<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Global_Macro_and_US_Tariff_Headwinds\" title=\"Global Macro and US Tariff Headwinds\">Global Macro and US Tariff Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#FY27_Earnings_Miss_and_Guidance_Risk\" title=\"FY27 Earnings Miss and Guidance Risk\">FY27 Earnings Miss and Guidance Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Competitive_Intensity_Among_Pharmaceutical_Formulations_Peers\" title=\"Competitive Intensity Among Pharmaceutical Formulations Peers\">Competitive Intensity Among Pharmaceutical Formulations Peers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Liquidity_Risk_and_FII_Selling_Pressure\" title=\"Liquidity Risk and FII Selling Pressure\">Liquidity Risk and FII Selling Pressure<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#How_to_Invest_in_Vineet_Laboratories\" title=\"How to Invest in Vineet Laboratories\">How to Invest in Vineet Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#FAQs_on_Vineet_Laboratories_Share_Price_Target_2026\" title=\"FAQs on Vineet Laboratories Share Price Target 2026\">FAQs on Vineet Laboratories Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#What_is_the_Vineet_Laboratories_share_price_target_for_2026\" title=\"What is the Vineet Laboratories share price target for 2026?\">What is the Vineet Laboratories share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#What_was_the_Vineet_Laboratories_share_price_target_for_2025\" title=\"What was the Vineet Laboratories share price target for 2025?\">What was the Vineet Laboratories share price target for 2025?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#Is_Vineet_Laboratories_a_good_investment_at_Rs_3425\" title=\"Is Vineet Laboratories a good investment at Rs 34.25?\">Is Vineet Laboratories a good investment at Rs 34.25?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#What_are_the_key_risks_to_the_Vineet_Laboratories_share_price_target_2026\" title=\"What are the key risks to the Vineet Laboratories share price target 2026?\">What are the key risks to the Vineet Laboratories share price target 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#What_is_the_52_week_high_and_low_of_Vineet_Laboratories\" title=\"What is the 52 week high and low of Vineet Laboratories?\">What is the 52 week high and low of Vineet Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#What_are_the_main_growth_catalysts_for_Vineet_Laboratories_in_2026\" title=\"What are the main growth catalysts for Vineet Laboratories in 2026?\">What are the main growth catalysts for Vineet Laboratories in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#How_does_Vineet_Laboratories_compare_to_its_peers\" title=\"How does Vineet Laboratories compare to its peers?\">How does Vineet Laboratories compare to its peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/vineet-laboratories-share-price-target-2026\/#What_is_the_Vineet_Laboratories_share_price_target_for_2027\" title=\"What is the Vineet Laboratories share price target for 2027?\">What is the Vineet Laboratories share price target for 2027?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Vineet_Laboratories_Share_Price_Target_2026_Key_Takeaways\"><\/span><strong>Vineet Laboratories Share Price Target 2026: Key Takeaways<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Vineet Laboratories share price target 2026:<\/strong> Rs 41.1 (20% upside from CMP Rs 34.25)<\/li>\n<li><strong>Bull case:<\/strong> Rs 49.7 | <strong>Bear case:<\/strong> Rs 27.4<\/li>\n<li><strong>Ticker:<\/strong> VINEETLAB | <strong>Sector:<\/strong> Pharmaceutical Formulations | <strong>MCap:<\/strong> Rs 120 crore<\/li>\n<li><strong>52W range:<\/strong> Rs 27.96 to Rs 49.99 | <strong>PE:<\/strong> 12x<\/li>\n<li><strong>Key catalyst:<\/strong> Q4 FY26 results and FY27 earnings confirmation in 2026<\/li>\n<li><strong>Key risk:<\/strong> FY27 earnings miss or FII outflows from Indian equities<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Vineet_Laboratories_Company_Overview\"><\/span><strong>Vineet Laboratories Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Vineet Laboratories (NSE: VINEETLAB) is a small-cap pharmaceutical formulations company manufacturing generic tablets, capsules, and liquids for domestic retail and institutional pharma supply. At CMP Rs 34.25 against a 52 week range of Rs 27.96 to Rs 49.99, the stock trades at a meaningful discount to its 52 week high. Market capitalisation is Rs 120 crore with trailing PE of 12x. Compared to peers in small-cap pharma sector, Vineet Laboratories is positioned as a potential re-rating candidate toward the Rs 41.1 price objective on FY27 earnings delivery.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>VINEETLAB<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceutical Formulations<\/td>\n<\/tr>\n<tr>\n<td>CMP (2026)<\/td>\n<td>Rs 34.25<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 49.99<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 27.96<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 120 crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing PE<\/td>\n<td>12x<\/td>\n<\/tr>\n<tr>\n<td>12-Month Analyst Target<\/td>\n<td>Rs 41.1<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 49.7<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 27.4<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_the_Vineet_Laboratories_Share_Price_Target_Set_at_Rs_411_for_2026\"><\/span><strong>Why Is the Vineet Laboratories Share Price Target Set at Rs 41.1 for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Recovery_and_Revenue_Acceleration\"><\/span><strong>FY27 Earnings Recovery and Revenue Acceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>Vineet Laboratories share price target<\/strong> of Rs 41.1 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for re-rating from CMP Rs 34.25.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Structural_Sector_Tailwinds_in_Pharmaceutical_Formulations\"><\/span><strong>Structural Sector Tailwinds in Pharmaceutical Formulations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Pharmaceutical Formulations sector is expanding on the back of India&#8217;s domestic demand growth, PLI scheme support, and rising corporate investment. Vineet Laboratories&#8217;s position among peers in small-cap pharma sector creates a structural growth runway, with sustained outperformance being one of the key conditions for the Rs 49.7 bull case to materialise.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\"><\/span><strong>RBI Rate Cut Cycle and Lower Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle in 2026 is reducing borrowing costs and stimulating end market demand. Lower interest costs improve Vineet Laboratories&#8217;s EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 41.1 analyst consensus.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Union_Budget_2026-27_Capex_Push_and_Policy_Support\"><\/span><strong>Union Budget 2026-27 Capex Push and Policy Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a favourable backdrop for Vineet Laboratories&#8217;s Pharmaceutical Formulations operations, improving the probability of achieving the Rs 41.1 price objective through FY27 earnings delivery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FII_Flow_Normalisation_After_the_2026_Tariff_Shock\"><\/span><strong>FII Flow Normalisation After the 2026 Tariff Shock<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 12x PE, Vineet Laboratories is positioned as a beneficiary of institutional reallocation toward the Rs 49.7 bull case over the medium term.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Vineet_Laboratories_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\"><\/span><strong>Vineet Laboratories Share Price Targets: Short Term, 12 Month, and Long Term<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Short_Term_Vineet_Laboratories_Share_Price_Target\"><\/span><strong>Short Term Vineet Laboratories Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Near-term support for Vineet Laboratories is anchored close to the 52 week low of Rs 27.96. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating from CMP Rs 34.25.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12-Month_Vineet_Laboratories_Share_Price_Target_2026\"><\/span><strong>12-Month Vineet Laboratories Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month <strong>Vineet Laboratories share price target 2026<\/strong> is Rs 41.1, implying approximately 20 percent upside from CMP Rs 34.25. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long_Term_Vineet_Laboratories_Share_Price_Target_FY27_to_FY28\"><\/span><strong>Long Term Vineet Laboratories Share Price Target: FY27 to FY28<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>long term Vineet Laboratories share price target<\/strong> for FY27 to FY28 is Rs 49.7 in the bull case, requiring full earnings delivery, re-rating among peers in small-cap pharma sector, and sustained institutional buying over a 2 to 3 year horizon.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_Scenarios_for_Vineet_Laboratories_in_2026\"><\/span><strong>Bull Case and Bear Case Scenarios for Vineet Laboratories in 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Vineet_Laboratories_Share_Price_Target_Rs_497\"><\/span><strong>Bull Case Vineet Laboratories Share Price Target: Rs 49.7<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>bull case Vineet Laboratories share price target<\/strong> of Rs 49.7 materialises when FY27 earnings beat analyst estimates, Pharmaceutical Formulations tailwinds accelerate, and FII flows return strongly to Indian equities, representing approximately 45 percent potential upside from CMP Rs 34.25.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Vineet_Laboratories_Share_Price_Target_Rs_274\"><\/span><strong>Bear Case Vineet Laboratories Share Price Target: Rs 27.4<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>bear case Vineet Laboratories share price target<\/strong> of Rs 27.4 materialises if FY27 earnings disappoint or FII outflows depress the broader market, risking a test of support near the 52 week low of Rs 27.96.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target<\/th>\n<th>Key Conditions<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 49.7<\/td>\n<td>FY27 beat, sector re-rating, FII inflows<\/td>\n<\/tr>\n<tr>\n<td>Base Case (Analyst Target)<\/td>\n<td>Rs 41.1<\/td>\n<td>In-line FY27 delivery, partial FII recovery<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 27.4<\/td>\n<td>FY27 miss, guidance cut, FII outflows persist<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_That_Could_Derail_the_Vineet_Laboratories_2026_Price_Objective\"><\/span><strong>Key Risks That Could Derail the Vineet Laboratories 2026 Price Objective<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Global_Macro_and_US_Tariff_Headwinds\"><\/span><strong>Global Macro and US Tariff Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Prolonged tariff tensions and global demand slowdown remain prominent macro risks to the <strong>Vineet Laboratories share price target<\/strong> of Rs 41.1, with FII outflows being the direct transmission mechanism to Indian equity valuations.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Miss_and_Guidance_Risk\"><\/span><strong>FY27 Earnings Miss and Guidance Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>An FY27 earnings miss or downward guidance revision would compress valuation multiples and is the most direct company-specific risk to the Rs 41.1 analyst price objective. Investors must monitor quarterly results and management commentary closely.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competitive_Intensity_Among_Pharmaceutical_Formulations_Peers\"><\/span><strong>Competitive Intensity Among Pharmaceutical Formulations Peers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Intensifying competition from peers in small-cap pharma sector could compress Vineet Laboratories&#8217;s market share and pricing power, a structural risk that must be weighed when assessing the defensibility of the earnings trajectory underpinning the Rs 41.1 analyst target for 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Liquidity_Risk_and_FII_Selling_Pressure\"><\/span><strong>Liquidity Risk and FII Selling Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. Investors should maintain position sizing discipline and stop losses to protect capital.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Vineet_Laboratories\"><\/span><strong>How to Invest in Vineet Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data<\/strong><\/a><\/p>\n<p>Before considering any investment based on the <strong>Vineet Laboratories share price target<\/strong> of Rs 41.1, review Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, margin trends, and management commentary on Pharmaceutical Formulations sector demand.<\/p>\n<p>Open a Demat account with a SEBI registered stockbroker to trade Vineet Laboratories (NSE: VINEETLAB) with full regulatory protection. Study the competitive landscape among peers in small-cap pharma sector before executing any position.<\/p>\n<p>Plan your entry using the 52 week low of Rs 27.96 as a key support reference. A confirmed FY27 earnings uptick validates the entry case for the Rs 41.1 price objective. Always set a stop loss below the 52 week low.<\/p>\n<p>Restrict any single stock to 3 to 5 percent of your total equity portfolio. Always consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.<\/p>\n<p><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Vineet Laboratories&#8217;s live share price and receive daily stock recommendations.<\/em><\/p>\n<div style=\"background: #C0392B; padding: 20px 24px; border-radius: 4px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 15px; font-weight: bold; margin: 0; line-height: 1.7;\"><strong>Disclaimer Note:<\/strong> The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Vineet_Laboratories_Share_Price_Target_2026\"><\/span><strong>FAQs on Vineet Laboratories Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Vineet_Laboratories_share_price_target_for_2026\"><\/span><strong>What is the Vineet Laboratories share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Vineet Laboratories share price target 2026 is Rs 41.1, implying approximately 20 percent upside from CMP Rs 34.25. Bull case is Rs 49.7, bear case is Rs 27.4.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Vineet_Laboratories_share_price_target_for_2025\"><\/span><strong>What was the Vineet Laboratories share price target for 2025?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 2025 price objective for Vineet Laboratories was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 41.1, reflecting FY27 growth potential from CMP Rs 34.25.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Vineet_Laboratories_a_good_investment_at_Rs_3425\"><\/span><strong>Is Vineet Laboratories a good investment at Rs 34.25?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At Rs 34.25, Vineet Laboratories offers potential upside toward Rs 41.1 if FY27 earnings recover. Whether this represents a good entry depends on individual risk tolerance. Consult a SEBI registered financial advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Vineet_Laboratories_share_price_target_2026\"><\/span><strong>What are the key risks to the Vineet Laboratories share price target 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks to the Vineet Laboratories share price target of Rs 41.1 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Pharmaceutical Formulations. Monitoring quarterly results is essential.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_Vineet_Laboratories\"><\/span><strong>What is the 52 week high and low of Vineet Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52 week high of Vineet Laboratories is Rs 49.99 and the 52 week low is Rs 27.96. At CMP Rs 34.25, the stock offers potential upside toward the Rs 41.1 price objective.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_growth_catalysts_for_Vineet_Laboratories_in_2026\"><\/span><strong>What are the main growth catalysts for Vineet Laboratories in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key catalysts include FY27 PAT recovery, Pharmaceutical Formulations tailwinds, RBI rate cuts in 2026, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Vineet_Laboratories_compare_to_its_peers\"><\/span><strong>How does Vineet Laboratories compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Vineet Laboratories operates in Pharmaceutical Formulations alongside peers in small-cap pharma sector. At CMP Rs 34.25 with MCap Rs 120 crore, it is a potential re-rating candidate toward the Vineet Laboratories share price target of Rs 41.1 on FY27 delivery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Vineet_Laboratories_share_price_target_for_2027\"><\/span><strong>What is the Vineet Laboratories share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The long-term Vineet Laboratories share price target for FY27 to FY28 is Rs 49.7 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Vineet Laboratories share price target 2026 is Rs 41.1, ~20% upside from CMP Rs 34.25. Bull Rs 49.7, bear Rs 27.4. 2026.<\/p>\n","protected":false},"author":28,"featured_media":132011,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3972],"class_list":["post-131446","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-share-price-target"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1782449760:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["82"],"rank_math_title":["Vineet Laboratories Share Price Target 2026: Rs 41.1 Analyst Forecast"],"rank_math_description":["The Vineet Laboratories share price target 2026 is Rs 41.1, ~20% upside from CMP Rs 34.25. Bull Rs 49.7, bear Rs 27.4. 2026."],"rank_math_focus_keyword":["Vineet Laboratories Share Price Target"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_wp_old_date":["2026-06-25"],"_thumbnail_id":["132011"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["21450"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Vineet-Laboratories-Share-Price-Target.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/131446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=131446"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/131446\/revisions"}],"predecessor-version":[{"id":132012,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/131446\/revisions\/132012"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/132011"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=131446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=131446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=131446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}